文献速递乳腺乳腺X线USMR

数字乳腺X线摄影与数字乳腺断层合成筛查异常后诊断管理路径的比较

Diagnostic Management Pathways for Workup of Abnormal Screening With Digital Mammography Versus Digital Breast Tomosynthesis.
PubMed 文献 · J Am Coll Radiol · 2025-04-10

该队列研究纳入2011至2020年六个乳腺癌症监测联盟登记处107家机构的筛查异常检查,比较数字乳腺断层合成(DBT)与数字乳腺X线摄影(DM)筛查异常后的诊断工作类型、频率、路径及诊断解决时间。DBT组首次工作常为超声(21.1% vs 4.7%),活检率更高(16.2% vs 14.0%;差值2.27;95%CI 1.97-2.58),但DM组手术切除活检比例更高(5.8% vs 3.2%;差值2.6;95%CI 2.19-3.01),诊断解决时间相似(中位10天)。

要点

  • DBT筛查异常后首次检查更多为超声(21.1% vs 4.7%)。
  • DBT组活检率16.2%,高于DM组14.0%(差值2.27;95%CI 1.97-2.58)。
  • DM组手术切除活检比例高于DBT组(5.8% vs 3.2%;差值2.6;95%CI 2.19-3.01)。

核心结论

  • DBT与DM筛查异常后的诊断工作路径类型存在差异;DBT后活检率更高,但DM后活检类型可能更具侵入性(手术切除)。

研究设计与样本

  • 队列研究,纳入2011至2020年六个乳腺癌症监测联盟登记处107家机构的筛查异常检查,比较DBT与DM异常后的诊断工作(诊断性DM、诊断性DBT、超声、MRI和活检,均在筛查异常后90天内)。

临床应用与阅片要点

  • 筛查异常后首次工作,DBT组超声占21.1%,DM组占4.7%。
  • 活检率DBT组16.2%,DM组14.0%,差值2.27(95%CI 1.97-2.58)。
  • DM组活检为手术切除者占5.8%,DBT组占3.2%,差值2.6(95%CI 2.19-3.01)。
  • 每1000例筛查异常的手术切除活检率:DBT组5.1,DM组8.0。
  • 诊断解决时间两组相似(中位数10天)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Our objective was to assess the transition from digital mammography (DM) to digital breast tomosynthesis (DBT) screening, the authors compared diagnostic workup type and frequency, workup pathways, and time to resolution of abnormal screening between DBT and DM.

METHODS: This cohort study included screening examinations with an abnormal results from 2011 to 2020 at 107 facilities across six Breast Cancer Surveillance Consortium registries. Diagnostic workup included diagnostic DM, diagnostic DBT, ultrasound, MRI, and biopsy within 90 days of the abnormal result on screening mammography. Workup modalities and number of workup procedures were compared using differences in proportion and 95% confidence intervals (CIs). Time to diagnostic resolution between DBT and DM was compared using a log-rank test.

RESULTS: Among 77,123 DBT and 197,589 abnormal DM screening examinations with abnormal results, the number of imaging modalities in the diagnostic pathway was similar. The first workup procedure was more often ultrasound after abnormal results on DBT compared with DM (21.1% versus 4.7%). Biopsy rates were higher for DBT versus DM (16.2% versus 14.0%; difference in proportions = 2.27; 95% CI, 1.97-2.58) with biopsies after DM versus DBT more likely surgical versus fine-needle aspiration or core (5.8% versus 3.2%; difference in proportions = 2.6; 95% CI, 2.19-3.01), resulting in a rate of excision biopsy per 1,000 screens with abnormal findings of 5.1 for DBT and 8.0 for DM. Time to diagnostic resolution was similar (median, 10 days).

CONCLUSIONS: This study revealed differences in the type of diagnostic workup pathways after abnormal results on screening DBT versus DM. Although the biopsy rate was higher after abnormal results on DBT, the biopsy type may be more invasive (surgical excision) after abnormal results on DM.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Henderson LM, Zhu W, Onega T, et al. Diagnostic Management Pathways for Workup of Abnormal Screening With Digital Mammography Versus Digital Breast Tomosynthesis. J Am Coll Radiol. 2025. PMID: 40216286. doi:10.1016/j.jacr.2025.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。